Bay Street News, May 10th, 2024

Reports First Quarter Results Above High End of Guidance Range on Key Financial Metrics Delivered $29.6 Million of Revenue, Reflecting […]

FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused […]

LOUISVILLE, Ky., May 10, 2024 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a […]

MIAMI, May 10, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a […]

— Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial […]

BOSTON, May 10, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]

The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features […]

SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth […]

PALM BEACH GARDENS, Fla., May 10, 2024 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) will host a conference call […]

VANCOUVER, British Columbia, May 10, 2024 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR) (OTCQB:LANRF) (FRA:6UF0) (“Lancaster”) a leader in critical […]